https://ir.sabbiotherapeutics.com/ 2026-11-06T13:02:38-05:00 daily 1.0 https://ir.sabbiotherapeutics.com/committee-details/audit-committee 2026-06-19T13:45:13-04:00 0.5 https://ir.sabbiotherapeutics.com/committee-details/compensation-committee 2026-06-19T13:44:11-04:00 0.5 https://ir.sabbiotherapeutics.com/committee-details/nominating-and-corporate-governance-committee 2024-05-29T08:24:19-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-biotherapeutics-host-virtual-rd-day-october-13-2021 2022-08-18T09:52:14-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-biotherapeutics-present-2022-hc-wainwright-global-investment-conference 2022-05-12T09:58:36-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/2022-annual-shareholder-meeting 2022-07-07T16:25:40-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-biotherapeutics-host-virtual-2022-annual-rd-portfolio-update 2022-08-18T13:19:02-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sidoti-virtual-investor-conference 2023-05-04T07:51:25-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/oppenheimer-34th-annual-healthcare-life-sciences-conference 2024-02-08T08:07:27-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/2024-cantor-global-healthcare-conference 2024-09-13T08:41:25-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-bio-rd-webinar-event-review-phase-1-topline-results-sab-142-potentially 2025-01-28T15:38:35-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-bio-2025-rd-presentation 2026-06-23T14:33:38-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/guggenheim-second-annual-healthcare-innovation-conference 2025-11-04T08:35:50-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/8th-annual-evercore-healthcare-conference 2025-11-04T08:36:10-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/guggenheim-emerging-outlook-biotech-summit-2026 2026-02-04T09:02:31-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/oppenheimer-36th-annual-healthcare-life-sciences-conference 2026-02-04T09:02:18-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/leerink-partners-global-healthcare-conference 2026-03-09T14:54:43-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-142-phase-1-data-adult-patients-autoimmune-t1d-expert-perspective 2026-03-10T08:35:30-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-bios-q2-2026-earnings-call 2026-07-30T08:31:14-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/citi-biopharma-back-school-conference 2026-09-01T08:31:41-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/sab-bios-q3-2026-earnings-call 2026-10-29T09:22:48-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/chardan-10th-annual-healthcare-conference 2026-10-23T19:49:56-04:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/citi-global-healthcare-conference 2026-11-09T10:54:21-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/9th-annual-evercore-healthcare-conference 2026-11-09T11:00:46-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/ubs-global-biopharma-conference 2026-11-09T11:02:32-05:00 0.5 https://ir.sabbiotherapeutics.com/events/event-details/jefferies-global-healthcare-conference 2026-11-09T13:51:47-05:00 0.5 https://ir.sabbiotherapeutics.com/investor-relations 2026-11-06T13:02:38-05:00 0.8 https://ir.sabbiotherapeutics.com/news-events/press-releases 2026-11-03T12:49:40-05:00 0.8 https://ir.sabbiotherapeutics.com/news-events/events 2026-10-23T12:07:00-04:00 0.8 https://ir.sabbiotherapeutics.com/news-events/presentations 2026-06-23T14:37:48-04:00 0.8 https://ir.sabbiotherapeutics.com/governance 2026-10-23T18:31:29-04:00 0.8 https://ir.sabbiotherapeutics.com/governance/committees 2026-10-23T19:42:33-04:00 0.8 https://ir.sabbiotherapeutics.com/analyst-coverage 2026-11-05T16:51:20-05:00 0.8 https://ir.sabbiotherapeutics.com/stock 2026-10-23T19:39:43-04:00 0.8 https://ir.sabbiotherapeutics.com/ir-resources/investor-faqs 2026-11-06T12:02:44-05:00 0.8 https://ir.sabbiotherapeutics.com/ir-resources/email-alerts 2026-10-23T12:11:32-04:00 0.8 https://ir.sabbiotherapeutics.com/ir-resources/rss-feeds 2026-10-23T12:11:01-04:00 0.8 https://ir.sabbiotherapeutics.com/ir-contact 2026-11-03T17:29:54-05:00 0.8 https://ir.sabbiotherapeutics.com/financial-information/quarterly-results 2026-10-23T12:09:14-04:00 0.8 https://ir.sabbiotherapeutics.com/financials/sec-filings 2026-10-23T18:39:30-04:00 0.8 https://ir.sabbiotherapeutics.com/leadership 2026-11-06T11:41:39-05:00 0.8 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-first-patient-dosed-phase-3-nih 2021-10-20T17:31:29-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-appoints-russell-beyer-chief-financial 2021-10-20T17:32:43-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-sab-185-receives-positive-dsmb 2021-10-20T17:33:18-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/big-cypress-acquisition-corp-announces-special-meeting 2021-10-20T17:36:59-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-awarded-additional-605m-barda-and-us 2021-10-20T17:37:38-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-completion-enrollment-phase-2a 2021-10-20T17:39:57-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-upcoming-september-virtual-investor 2021-10-20T17:41:16-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-nonclinical-data-demonstrating-sab 2021-10-20T17:41:55-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-ladenburg-thalmann-annual-healthcare 2021-10-20T17:42:26-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-publication-preclinical-data 2021-10-20T17:43:07-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/big-cypress-acquisition-corp-announces-confidential-submission-s 2021-10-20T17:43:41-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-doses-first-participant-phase-2a-trial-sab 2021-10-20T17:44:31-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-list-nasdaq-through-merger-big-cypress 2021-10-20T17:45:07-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-participate-expert-panel-bio-digital-2021 2021-10-20T17:45:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-appoints-carlos-carrillo-phd-senior-vice 2021-10-20T17:46:11-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-rbc-capital-markets-2021-global 2021-10-20T17:46:37-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-doses-first-patient-sab-185-treatment-covid 2021-10-20T17:47:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-upcoming-march-investor-conferences 2021-10-20T17:47:46-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-new-appointments-its-board 2021-10-20T17:48:14-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-awarded-575m-barda-and-us-department-defense 2021-10-20T17:48:49-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-first-patient-dosed-phase-1b 2021-10-20T17:49:45-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-first-participant-dosed-phase-1 2021-10-20T17:50:12-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-awarded-356m-us-department-defense-covid-19 2021-10-20T17:50:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-first-participant-dosed-phase-1-0 2021-10-20T18:00:03-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-closes-series-b-funding 2021-10-20T18:00:47-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-president-and-ceo-eddie-j-sullivan-phd 2021-10-20T18:01:18-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-confirms-neutralizing-antibodies-sars-cov-2 2021-10-20T18:01:48-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-advances-therapeutic-covid-19-partnership 2021-10-20T18:02:18-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/csl-behring-and-sab-biotherapeutics-join-forces-deliver-new 2021-10-20T18:02:45-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-awarded-27m-contract-develop-novel-rapid 2021-10-20T18:03:15-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-delays-development-usd-discovery-district 2021-10-20T18:03:45-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-research-collaboration-csl-behring 2021-10-20T18:04:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-raises-22m-series-2-round 2021-10-21T11:33:07-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/south-dakota-equity-partners-invests-105m-sab-biotherapeutics 2021-10-21T11:33:40-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/usd-discovery-district-breaks-ground-first-building-project 2021-10-21T11:34:21-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/ebola-successfully-neutralized-latest-generation-polyclonal 2021-10-21T11:35:05-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/usd-discovery-district-announces-anchor-tenants-innovation 2021-10-21T11:35:37-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-expands-vac-team 2021-10-21T11:36:11-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-capra-awarded-225k-nih-broaden-novel-immunotherapy-platform 2021-10-21T11:36:56-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/first-treatment-mers-appears-safe-nih-phase-i-clinical-trial 2021-10-21T11:37:28-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/first-human-trial-new-immunotherapy-approach-shows-efficacy 2021-10-21T11:38:01-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-launches-utah-based-subsidiary-sab-capra-llc 2021-10-21T12:04:28-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-pharm-groundbreaking-highlights-broad-impact 2021-10-21T12:05:02-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-integrates-operations-new-production 2021-10-21T12:05:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/pharmaceutical-entrepreneur-william-j-polvino-md-joins-sab 2021-10-21T12:06:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-strengthens-board-directors-appointment 2021-10-21T12:06:48-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-names-christoph-bausch-chief-science-officer 2021-10-21T12:07:21-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-host-virtual-rd-day-october-13-2021 2021-10-22T18:38:11-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-debuts-publicly-traded-next-generation 2021-10-25T07:40:43-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-reports-third-quarter-2021-financial-results 2021-11-22T07:00:40-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-sab-176-met-its-primary-endpoint 2021-12-01T07:01:42-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-immunotherapy-proposal-among-top-platform 2021-12-14T15:51:43-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-receives-142-million-sbir-grant-advance 2021-12-14T15:53:21-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-contract-barda-advance-first-mers 2021-12-14T15:54:47-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/phase-i-clinical-trials-underway-first-mers-treatment 2021-12-14T15:56:59-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/new-study-university-maryland-school-medicine-researchers-finds 2021-12-14T16:00:00-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-produces-new-human-antibody-treatment-mers 2021-12-14T16:02:20-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-and-us-army-team-treat-hantavirus 2021-12-14T16:04:19-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/human-antibodies-produced-dna-vaccinated-cows-protect-lethal 2021-12-14T16:05:49-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-sab-185-retains-neutralization 2021-12-16T06:00:21-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-added-nasdaq-biotechnology-index 2021-12-20T06:00:17-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-reports-positive-phase-2-virology-data 2022-01-24T06:01:10-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-update-phase-3-nih-activ-2-trial 2022-02-25T06:00:36-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-publication-nonclinical-data 2022-03-01T19:30:59-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-reports-nih-discontinuing-phase-3-activ-2 2022-03-02T06:01:03-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-and-reports-full 2022-03-29T16:30:54-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-appoints-mark-j-ratain-md-companys-board 2022-04-05T06:01:31-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-2022-hc-wainwright-global-investment 2022-05-12T09:42:33-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-q1-2022-financial 2022-05-12T16:16:02-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-chief-operating-officer-dr-christoph-bausch 2022-05-31T08:30:54-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-appointment-alexandra-kropotova-md 2022-06-06T08:30:37-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-hosts-us-representatives-dusty-johnson-and 2022-07-05T08:01:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-election-rear-admiral-retired 2022-07-11T08:00:58-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-host-virtual-2022-annual-rd-portfolio-update 2022-08-04T08:30:50-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-advancing-pipeline-and-expands-treatment-c 2022-08-09T16:30:34-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-q2-2022-financial 2022-08-10T08:15:18-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-new-data-isirv-options-xi-conference 2022-09-23T08:30:42-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-unveils-new-data-isirv-options-xi-conference 2022-09-28T08:01:18-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-exclusive-manufacturing 2022-10-27T08:30:58-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-presents-overview-diversitabtm-platform-and 2022-11-03T09:00:59-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-presents-novel-biologic-therapeutics 2022-11-08T08:30:43-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-q3-2022-financial 2022-11-15T08:30:42-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-initiates-ind-enabling-glp-toxicology-study 2022-11-21T08:15:28-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-79-million-private-placement 2022-12-07T17:16:15-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-cmo-selected-present-january-2023-biotech 2022-12-15T08:30:42-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-novel-diversitabtm-platform-proven-develop 2023-01-05T08:00:29-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-cmo-alexandra-kropotova-deliver-presentation 2023-01-09T08:01:08-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-successfully-concludes-ind-enabling-glp 2023-01-10T08:01:28-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-receives-additional-82-million-closeout-dod 2023-01-18T08:00:20-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-ceo-eddie-sullivan-phd-present-next 2023-01-19T08:00:52-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-co-founder-president-ceo-eddie-sullivan-0 2023-02-09T12:45:46-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/icr-hosts-sab-biotherapeutics-ceo-eddie-sullivan-welcome-arena 2023-03-24T08:44:14-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-full-year-2022 2023-03-31T17:00:33-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-appointment-erick-lucera-cfa-board 2023-04-04T08:00:46-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-granted-fast-track-designation-fda-sab-176 2023-04-13T08:30:51-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-us-fda-grants-breakthrough-therapy 2023-04-18T08:30:25-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-positive-results-phase-3-trial-sab 2023-04-26T08:31:04-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-sidoti-virtual-investor-conference 2023-05-03T17:00:36-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-presents-positive-phase-1-and-2a-data-sab 2023-05-04T08:30:56-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-progress-us-fdas-phased-review 2023-05-09T08:30:28-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-first-publication-promising 2023-05-12T08:30:40-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-q1-2023-financial 2023-05-16T08:30:21-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-presents-virtual-2023-rd-day-portfolio 2023-05-19T08:30:15-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-novel-human-igg-platform-positive 2023-05-30T08:30:34-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-presents-positive-ind-enabling-glp 2023-06-21T08:30:33-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-company-update-q2-2023-financial 2023-08-21T08:30:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-private-placement-130-million 2023-10-02T07:30:45-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-approves-appointment-andrew-moin-board 2023-10-05T07:30:20-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-co-founder-president-ceo-talks-fierce 2023-10-16T14:14:07-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sioux-falls-business-journal-publication-sab-biotherapeutics 2023-10-16T14:15:08-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-receives-australian-approval-commence-phase 2023-10-19T07:30:25-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-appoints-michael-g-king-jr-chief-financial 2023-10-24T07:30:19-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-piper-sandler-healthcare-conference 2023-11-09T07:30:18-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-q3-2023-financial-results-and 2023-11-14T07:15:34-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-completion-671-million-financing 2023-11-14T07:30:15-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-appoints-katie-ellias-board-directors 2023-11-20T07:30:39-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-commencement-human-phase-1 2023-11-29T07:30:30-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-interview-diabetes-daily-how-genetically 2023-12-12T10:41:39-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-1-10-reverse-stock-split 2024-01-02T16:30:14-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-regains-compliance-nasdaq-minimum-bid-price 2024-01-23T17:58:59-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-executive-leadership-change 2024-02-02T07:30:33-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-oppenheimer-34th-annual-healthcare 2024-02-08T08:00:35-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-bio-ceo-investor-conference 2024-02-23T08:00:32-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-clinical-partnership-naval-medical 2024-03-25T10:15:38-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-reports-full-year-2023-operating-and 2024-03-29T07:59:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-needham-virtual-healthcare 2024-04-04T07:15:56-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-innodia-annual-meeting 2024-04-08T07:15:38-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-provides-sab-142-trial-update 2024-04-16T07:15:31-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-appoints-jay-skyler-md-board-directors 2024-05-06T07:15:09-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-q1-2024-financial-results-and 2024-05-20T21:16:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/fda-provides-clearance-ind-application-type-1-diabetes-therapy 2024-05-21T07:15:16-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-announces-departure-chief-financial-officer 2024-05-30T16:45:17-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-present-american-diabetes-association-84th 2024-06-18T13:10:10-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-biotherapeutics-rebrands-sab-bio 2024-06-20T07:20:11-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-appoints-lucy-chief-financial-officer 2024-07-31T07:30:16-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-founding-clinical-advisory-board-guide 2024-08-05T07:30:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-second-quarter-2024-financial-results-and 2024-08-08T17:51:29-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-european-association-study-diabetes-60th-annual 2024-09-04T07:05:41-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-provides-sab-142-clinical-trial-progress-update-european 2024-09-09T07:00:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-ceo-participate-fireside-chat-2024-cantor-global 2024-09-13T07:00:39-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-ceo-participate-fireside-chat-guggenheim-securities 2024-10-31T07:00:59-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-third-quarter-2024-financial-results-and 2024-11-06T17:05:31-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-rd-webinar-event-review-phase-1-topline 2025-01-23T07:00:21-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-positive-topline-phase-1-clinical-results 2025-01-28T07:00:26-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-upcoming-investor-conferences 2025-01-31T07:00:36-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-full-year-2024-operating-and-financial-results 2025-03-31T08:17:30-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-q1-2025-financial-results-and-provides-company 2025-05-09T09:01:08-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-oversubscribed-175-million-private-placement 2025-07-21T07:30:31-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-second-quarter-financial-results-and-highlights 2025-08-07T07:30:46-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-deliver-five-presentations-related-sab-142-2025-annual 2025-09-03T16:05:22-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-highlights-data-multiple-presentations-easd 2025-09-19T07:25:01-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-upcoming-investor-conferences-0 2025-11-04T08:00:53-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-data-international-society-pediatric-and 2025-11-04T08:30:37-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-third-quarter-financial-results-and-recent 2025-11-13T17:00:44-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-data-showcasing-progress-development-sab-142 2025-12-08T08:00:24-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-positive-confirmatory-clinical-results-phase-1 2025-12-17T08:00:21-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/first-patient-dosed-sab-bios-safeguard-clinical-trial-sab-142 2025-12-18T08:00:52-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-44th-annual-jp-morgan-healthcare-conference 2026-01-06T08:01:12-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-strengthens-board-directors-appointment-new-chair-and 2026-01-07T08:00:37-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-upcoming-investor-conferences-1 2026-02-04T09:00:50-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-upcoming-investor-conferences-2 2026-03-02T09:00:45-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-full-year-2025-financial-results-and-business 2026-03-09T17:17:02-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-additional-phase-1-data-sab-142-adult-patients 2026-03-10T07:31:16-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-proposed-public-offering-common-stock-and-pre 2026-03-17T16:01:57-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-pricing-85-million-public-offering-common 2026-03-17T22:46:50-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-announces-closing-85-million-public-offering-common 2026-03-19T16:01:15-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-additional-data-supporting-unique-profile-sab 2026-04-15T08:00:43-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-presents-additional-clinical-and-mechanistic-data-sab 2026-04-22T07:00:43-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-host-first-quarter-2026-financial-results-conference 2026-05-05T08:30:36-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-q1-2026-financial-results-and-recent-business 2026-05-12T07:30:30-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-data-sab-142-american-diabetes-associations-2026 2026-05-29T09:41:47-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/breakthrough-t1d-awards-grant-support-prise-hatg-study-sab-142 2026-07-07T08:00:32-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-host-second-quarter-2026-financial-results-conference 2026-07-30T08:30:57-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-q2-2026-financial-results-and-provides-business 2026-08-06T07:30:34-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-upcoming-investor-conferences-3 2026-09-01T08:30:36-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-sab-142-data-62nd-annual-meeting-european 2026-09-22T08:30:33-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-present-sab-142-data-inaugural-breakthrough-t1d-clinical 2026-10-01T09:12:00-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-receives-fda-fast-track-designation-sab-142-stage-3-type 2026-10-13T08:31:10-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-chardan-10th-annual-healthcare-conference 2026-10-14T08:31:31-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-host-third-quarter-2026-financial-results-conference 2026-10-29T08:31:26-04:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-reports-q3-2026-financial-results-and-provides-business 2026-11-05T07:30:57-05:00 0.5 https://ir.sabbiotherapeutics.com/news-releases/news-release-details/sab-bio-participate-upcoming-investor-conferences-4 2026-11-09T08:30:58-05:00 0.5 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-1/0001493152-20-023047 2020-12-07T17:03:43-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-1a/0001493152-21-000090 2021-01-04T17:23:58-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-1a/0001493152-21-000441 2021-01-07T15:10:53-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-a12b/0001493152-21-000529 2021-01-08T10:45:34-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-000758 2021-01-11T16:56:07-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-000760 2021-01-11T16:58:07-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-000763 2021-01-11T17:00:42-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-000765 2021-01-11T17:03:27-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-000768 2021-01-11T17:07:04-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-000771 2021-01-11T17:10:37-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-21-000106 2021-01-12T06:08:52-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b4/0001493152-21-000839 2021-01-12T16:10:24-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-000842 2021-01-12T16:13:56-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-001028 2021-01-14T13:33:17-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-001029 2021-01-14T13:33:59-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-001030 2021-01-14T13:37:14-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-001543 2021-01-21T16:55:19-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-002582 2021-02-04T08:33:23-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-000103 2021-02-10T00:33:03-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-21-000182 2021-02-10T00:33:21-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-000525 2021-02-10T00:33:22-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-000526 2021-02-10T00:33:23-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-000442 2021-02-10T00:33:24-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13g/0001140361-21-005965 2021-02-24T10:02:14-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/nt-10-k/0001493152-21-007554 2021-04-01T06:20:46-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-k/0001493152-21-007884 2021-04-02T17:00:48-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/nt-10-q/0001493152-21-011821 2021-05-18T01:03:32-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-012522 2021-05-21T16:34:02-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001493152-21-012524 2021-05-21T16:34:11-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-014937 2021-06-22T09:05:44-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-014936 2021-06-22T09:07:56-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-014998 2021-06-22T16:04:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-014997 2021-06-22T16:04:42-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016119 2021-07-06T06:05:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016399 2021-07-08T06:06:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016397 2021-07-08T06:07:27-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016425 2021-07-08T09:07:35-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016492 2021-07-09T06:08:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016578 2021-07-12T06:07:52-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016667 2021-07-13T06:06:32-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-016970 2021-07-16T06:07:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-017375 2021-07-21T06:08:20-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001493152-21-019063 2021-08-09T17:15:16-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-019430 2021-08-12T06:13:27-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-20-012573 2021-08-15T22:35:30-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-019845 2021-08-16T06:32:24-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-019840 2021-08-16T06:35:29-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-4/0001493152-21-020329 2021-08-17T06:15:02-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-022074 2021-09-07T10:38:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-4a/0001493152-21-022195 2021-09-08T15:03:39-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-022215 2021-09-08T17:03:04-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-4a/0001493152-21-023292 2021-09-22T06:08:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-023397 2021-09-22T17:17:38-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-21-003620 2021-09-23T08:07:36-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001493152-21-023492 2021-09-23T16:39:49-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001493152-21-023619 2021-09-24T17:03:16-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-023691 2021-09-27T06:12:55-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-023933 2021-09-28T09:13:46-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-024531 2021-10-04T17:17:21-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-024641 2021-10-05T17:02:34-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-024640 2021-10-05T17:02:45-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-024890 2021-10-07T09:31:21-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-025138 2021-10-12T09:13:02-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-025137 2021-10-12T09:13:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-025286 2021-10-13T12:57:39-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/425/0001493152-21-025288 2021-10-13T13:02:39-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-025508 2021-10-15T10:50:18-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-025510 2021-10-15T10:53:39-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13g/0001104659-21-127418 2021-10-19T09:53:26-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-025933 2021-10-21T07:33:12-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/25-nse/0001354457-21-001207 2021-10-22T16:20:10-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026141 2021-10-22T21:24:57-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026138 2021-10-22T21:24:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026142 2021-10-22T21:24:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026140 2021-10-22T21:24:59-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026153 2021-10-22T21:35:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026152 2021-10-22T21:35:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026155 2021-10-22T21:35:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026149 2021-10-22T21:35:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026151 2021-10-22T21:35:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026144 2021-10-22T21:35:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026148 2021-10-22T21:35:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026154 2021-10-22T21:35:12-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026147 2021-10-22T21:35:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026150 2021-10-22T21:35:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026146 2021-10-22T21:35:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001493152-21-026362 2021-10-26T21:45:29-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026388 2021-10-26T21:56:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026391 2021-10-26T21:56:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026387 2021-10-26T21:56:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026379 2021-10-26T21:56:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026383 2021-10-26T21:56:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026380 2021-10-26T21:56:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026392 2021-10-26T21:56:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026394 2021-10-26T21:56:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026393 2021-10-26T21:56:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026386 2021-10-26T21:56:10-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026389 2021-10-26T21:56:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026390 2021-10-26T21:56:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026384 2021-10-26T21:56:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026382 2021-10-26T21:56:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-026385 2021-10-26T21:56:48-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-026649 2021-10-28T17:23:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13d/0001493152-21-026888 2021-11-01T16:56:59-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13d/0001493152-21-026891 2021-11-01T16:59:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13d/0001493152-21-026918 2021-11-02T06:06:26-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/nt-10-q/0001493152-21-028684 2021-11-15T17:28:17-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-028917 2021-11-16T15:11:34-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-029370 2021-11-19T16:07:56-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001493152-21-029395 2021-11-19T16:47:14-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-029397 2021-11-19T16:52:07-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-21-029460 2021-11-22T07:44:17-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4a/0001493152-21-029528 2021-11-22T14:33:56-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001493152-21-029551 2021-11-22T16:04:20-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-ka/0001493152-21-029557 2021-11-22T16:09:02-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4a/0001493152-21-029889 2021-11-24T19:43:12-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-1/0001493152-21-030474 2021-12-03T17:20:32-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-21-004712 2021-12-16T06:06:09-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001193125-21-369110 2021-12-29T16:03:36-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-22-000588 2022-01-06T17:03:52-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001493152-22-000737 2022-01-10T06:06:56-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-8/0001193125-22-024568 2022-02-01T16:05:35-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13ga/0001140361-22-004820 2022-02-11T15:41:25-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13ga/0001104659-22-021075 2022-02-14T06:23:26-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-21-014743 2022-03-08T22:17:35-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001193125-21-354834 2022-03-08T22:20:49-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-020335 2022-03-08T22:36:29-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-023332 2022-03-08T22:37:20-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-022881 2022-03-08T22:38:49-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-21-009347 2022-03-08T22:39:54-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-023246 2022-03-08T22:42:14-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-21-010747 2022-03-08T22:42:57-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001493152-21-022197 2022-03-08T22:44:43-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011662 2022-03-18T21:24:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011666 2022-03-18T21:24:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011663 2022-03-18T21:24:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011664 2022-03-18T21:24:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011659 2022-03-18T21:25:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011661 2022-03-18T21:25:04-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011667 2022-03-18T21:25:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011665 2022-03-18T21:25:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000899243-22-011660 2022-03-18T21:25:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-k/0000950170-22-004935 2022-03-29T16:54:16-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/pos-am/0001193125-22-111227 2022-04-20T17:00:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-22-001086 2022-04-27T06:12:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001193125-22-133785 2022-04-29T16:52:20-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-22-009722 2022-05-12T16:43:16-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0000950170-22-009899 2022-05-16T06:17:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-031398 2022-05-23T17:48:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-031401 2022-05-23T17:56:18-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0000950170-22-010672 2022-05-25T17:06:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13da/0001193125-22-162385 2022-05-27T17:11:45-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-011205 2022-06-06T13:37:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0000950170-22-011238 2022-06-07T06:05:35-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-011250 2022-06-07T08:03:17-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001209191-22-034905 2022-06-07T19:03:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-034919 2022-06-07T20:13:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-012460 2022-07-05T16:33:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-012572 2022-07-11T09:13:23-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001209191-22-042071 2022-07-13T17:59:40-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-22-016221 2022-08-10T06:13:10-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0000950170-22-017558 2022-08-17T17:30:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-1/0001193125-22-226637 2022-08-23T06:07:28-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-049168 2022-09-08T16:34:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13da/0000950170-22-018253 2022-09-08T17:06:11-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13da/0000950170-22-018255 2022-09-08T17:10:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-049950 2022-09-14T17:17:42-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-050082 2022-09-15T16:47:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-050081 2022-09-15T16:47:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-050094 2022-09-15T17:04:18-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-050093 2022-09-15T17:04:20-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-050106 2022-09-15T17:19:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-050105 2022-09-15T17:21:00-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-018805 2022-09-23T09:02:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-018944 2022-09-28T09:03:23-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-019082 2022-09-30T09:16:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-019398 2022-10-07T17:12:00-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-019554 2022-10-13T17:21:55-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-020881 2022-11-01T17:08:44-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-022367 2022-11-07T09:33:33-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-22-025094 2022-11-14T17:30:55-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0000950170-22-025415 2022-11-18T09:16:35-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-025544 2022-11-21T16:47:53-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-060440 2022-12-09T09:04:25-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-060442 2022-12-09T09:06:12-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001209191-22-060501 2022-12-09T16:35:04-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-22-026346 2022-12-12T09:10:18-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13da/0000950170-22-026678 2022-12-16T16:36:48-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-000243 2023-01-05T16:27:02-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-000472 2023-01-09T09:03:39-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-000576 2023-01-10T09:02:38-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-001990 2023-01-27T16:37:26-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/pos-am/0001437749-23-002488 2023-02-03T16:59:12-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0001437749-23-002490 2023-02-03T17:00:16-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-002624 2023-02-07T09:05:35-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-000316 2023-02-09T06:12:41-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/5/0001437749-23-003040 2023-02-10T16:19:00-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-000384 2023-02-13T06:11:48-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-005165 2023-03-02T09:20:31-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-005167 2023-03-02T09:24:13-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001437749-23-005686 2023-03-07T17:06:30-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-001308 2023-03-14T00:10:34-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001437749-23-002806 2023-03-14T00:14:36-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-006910 2023-03-16T16:31:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-006908 2023-03-16T16:31:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-006909 2023-03-16T16:31:57-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-006911 2023-03-16T16:33:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-006913 2023-03-16T16:35:24-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-007867 2023-03-24T17:23:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-008871 2023-03-31T17:14:10-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/nt-10-k/0001437749-23-008874 2023-03-31T17:15:15-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-009184 2023-04-04T09:36:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001437749-23-009552 2023-04-05T17:03:35-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001437749-23-009554 2023-04-05T17:06:20-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-010220 2023-04-14T09:00:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-k/0001437749-23-010343 2023-04-14T17:04:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-010655 2023-04-19T17:08:47-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-011514 2023-04-28T09:06:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-ka/0001437749-23-011640 2023-04-28T16:36:10-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-ka/0001437749-23-011641 2023-04-28T16:48:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0001437749-23-011878 2023-05-01T16:09:59-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0001437749-23-013303 2023-05-09T16:17:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-001353 2023-05-10T06:12:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-014272 2023-05-12T17:23:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001437749-23-014634 2023-05-15T16:53:24-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-001464 2023-05-18T06:11:34-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0001437749-23-015192 2023-05-19T09:32:18-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001437749-23-012799 2023-06-08T00:10:17-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-004662 2023-06-08T00:10:57-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-017353 2023-06-14T08:56:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-005068 2023-06-17T00:12:00-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001437749-23-014291 2023-06-17T00:12:00-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-017924 2023-06-21T08:52:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/rw/0001437749-23-017991 2023-06-21T16:07:16-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-019198 2023-07-03T13:21:52-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/pos-am/0001437749-23-019653 2023-07-10T17:23:10-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/aw/0001437749-23-021177 2023-07-31T16:35:19-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001437749-23-021186 2023-07-31T16:45:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/nt-10-q/0001437749-23-023658 2023-08-14T16:08:59-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001437749-23-024224 2023-08-21T08:26:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-043561 2023-08-21T08:29:11-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0001437749-23-024291 2023-08-21T16:18:18-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-002536 2023-08-31T06:13:15-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-009436 2023-09-29T00:11:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0000950170-23-044828 2023-09-29T00:12:23-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-051127 2023-10-02T16:11:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0000950170-23-052624 2023-10-10T16:08:47-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001062993-23-019183 2023-10-10T16:27:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/d/0001209191-23-052843 2023-10-16T16:10:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13g/0001493152-23-037345 2023-10-16T16:10:25-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/pre-14a/0000950170-23-054396 2023-10-20T16:36:01-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-054936 2023-10-24T17:35:15-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001062993-23-019668 2023-10-24T17:40:52-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-056048 2023-10-27T17:03:26-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-010671 2023-10-30T01:16:42-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-010559 2023-10-30T01:17:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0000950170-23-049985 2023-10-30T01:20:38-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0000950170-23-056434 2023-10-30T17:05:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0000950170-23-058886 2023-11-03T16:42:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-058894 2023-11-03T16:54:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0000950170-23-058898 2023-11-03T17:02:23-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-23-063076 2023-11-13T16:53:15-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001062993-23-020791 2023-11-14T18:45:11-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/defa14a/0000950170-23-063776 2023-11-14T19:02:34-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-063918 2023-11-14T19:21:52-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-ka/0000950170-23-063774 2023-11-14T20:56:44-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4a/0001062993-23-020902 2023-11-15T16:33:46-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4a/0000950170-23-064323 2023-11-15T21:19:55-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3a/0000950170-23-065147 2023-11-20T16:46:44-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-065178 2023-11-20T17:03:58-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0000950170-23-065888 2023-11-22T16:34:37-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-065895 2023-11-22T16:47:00-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001062993-23-021502 2023-11-28T16:09:03-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-066395 2023-11-28T16:09:03-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-066394 2023-11-28T16:09:13-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-23-003472 2023-11-29T06:11:53-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-23-066553 2023-11-29T07:42:40-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-066901 2023-11-30T08:03:42-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-067072 2023-11-30T17:03:20-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13g/0000921895-23-002708 2023-12-04T16:39:15-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-23-068922 2023-12-08T08:26:06-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/pre-14a/0000950170-23-069098 2023-12-08T17:27:37-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0000950170-23-070950 2023-12-18T09:35:22-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-23-012205 2023-12-29T00:14:23-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0000950170-23-066005 2023-12-29T00:14:23-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-000543 2024-01-03T09:03:24-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-005793 2024-01-19T16:24:13-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-007480 2024-01-25T17:07:34-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b5/0000950170-24-007904 2024-01-26T16:02:31-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-007941 2024-01-26T16:17:40-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-010093 2024-02-02T07:57:31-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13ga/0001104659-24-022778 2024-02-14T06:29:57-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13g/0000902664-24-001535 2024-02-14T07:04:41-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/sc-13ga/0001493152-24-006626 2024-02-14T16:09:27-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-8/0000950170-24-019383 2024-02-23T16:28:38-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-019430 2024-02-23T16:44:32-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-019432 2024-02-23T16:52:53-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-019441 2024-02-23T17:05:31-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-019434 2024-02-23T17:06:17-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-019460 2024-02-23T17:06:25-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-028666 2024-03-08T16:31:54-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-k/0000950170-24-038219 2024-03-29T06:06:46-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-038429 2024-03-29T09:40:19-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-044497 2024-04-15T17:17:52-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-054868 2024-05-08T06:12:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0000950170-24-059747 2024-05-14T17:03:11-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/nt-10-q/0000950170-24-060524 2024-05-15T16:37:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-24-062367 2024-05-20T16:08:29-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-062656 2024-05-21T07:33:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0000950170-24-066767 2024-05-30T17:16:46-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-066856 2024-05-31T06:04:21-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0000950170-24-076849 2024-06-24T17:02:24-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-078622 2024-06-27T17:33:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084293 2024-07-17T16:34:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084294 2024-07-17T16:34:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084291 2024-07-17T16:34:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084296 2024-07-17T16:34:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084292 2024-07-17T16:34:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084290 2024-07-17T16:34:11-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084288 2024-07-17T16:34:16-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084295 2024-07-17T16:35:14-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-084299 2024-07-17T16:35:15-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-088247 2024-07-31T08:05:29-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0000950170-24-088675 2024-07-31T17:03:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-24-094084 2024-08-08T16:34:27-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-8/0000950170-24-095538 2024-08-12T17:17:52-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-096405 2024-08-13T17:02:43-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-24-104564 2024-09-09T08:28:17-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-121563 2024-11-05T16:47:35-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-24-122443 2024-11-06T17:07:19-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-24-141672 2024-12-31T17:53:18-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-25-009474 2025-01-28T07:16:54-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-25-014627 2025-02-05T17:04:35-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/0000950170-25-020485 2025-02-14T09:02:49-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-k/0000950170-25-046994 2025-03-31T06:07:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-048551 2025-04-01T16:22:34-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-8/0000950170-25-050587 2025-04-03T17:20:12-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-25-067554 2025-05-09T08:49:06-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0000950170-25-080361 2025-06-02T17:03:33-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-25-096645 2025-07-17T17:02:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0000950170-25-097078 2025-07-21T07:32:49-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-098365 2025-07-24T16:32:22-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001062993-25-013136 2025-07-24T16:33:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/d/0000950123-25-007031 2025-08-05T17:09:27-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0000950170-25-104566 2025-08-07T07:36:21-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/pre-14a/0001833214-25-000003 2025-08-19T16:31:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-112045 2025-08-28T17:02:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-112043 2025-08-28T17:02:31-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-112047 2025-08-28T17:04:11-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-112056 2025-08-28T17:11:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0000950170-25-112077 2025-08-28T17:18:44-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0001193125-25-192856 2025-08-29T17:25:07-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0001833214-25-000011 2025-09-02T17:28:15-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-211490 2025-09-22T17:02:37-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3a/0001193125-25-211553 2025-09-22T17:17:08-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-25-220721 2025-09-26T16:48:20-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-25-225119 2025-09-30T16:39:02-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-25-003220 2025-10-01T06:10:04-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001012975-25-000592 2025-10-01T16:08:04-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-226846 2025-10-01T16:37:02-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0001493152-25-016846 2025-10-03T16:06:40-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13d/0001346824-25-000015 2025-10-03T16:27:36-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0001213900-25-096128 2025-10-03T16:31:57-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001193125-25-277813 2025-11-12T16:46:02-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001193125-25-280572 2025-11-14T06:11:11-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0000902664-25-005039 2025-11-14T16:25:08-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0000921895-25-003116 2025-11-14T16:29:26-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-317688 2025-12-12T16:48:51-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-8/0001193125-25-319278 2025-12-15T16:36:02-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-324963 2025-12-18T16:42:22-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-324970 2025-12-18T16:46:59-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-324976 2025-12-18T16:47:18-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-324991 2025-12-18T16:51:37-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-325002 2025-12-18T16:55:44-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-25-325007 2025-12-18T16:57:00-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-25-335267 2025-12-29T16:06:10-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-3/0001193125-25-335445 2025-12-30T10:10:26-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-005487 2026-01-07T08:31:31-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001193125-26-006407 2026-01-07T16:40:43-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/3/0001193125-26-006411 2026-01-07T16:41:09-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-006427 2026-01-07T16:42:59-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-006435 2026-01-07T16:45:02-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/effect/9999999995-26-000101 2026-01-08T06:04:59-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-010515 2026-01-12T16:51:11-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0001193125-26-019535 2026-01-22T16:35:39-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-039508 2026-02-05T16:37:25-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-039524 2026-02-05T16:43:16-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-039537 2026-02-05T16:47:34-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-039564 2026-02-05T16:53:06-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-039577 2026-02-05T16:56:43-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001493215-26-000048 2026-02-17T08:48:24-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0000921895-26-000472 2026-02-17T16:24:30-05:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-k/0001833214-26-000003 2026-03-09T17:13:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-099376 2026-03-10T07:38:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13da/0001346824-26-000072 2026-03-11T16:54:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b5/0001193125-26-110666 2026-03-17T16:02:27-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b5/0001193125-26-114728 2026-03-19T06:05:51-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-114730 2026-03-19T06:07:38-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13da/0001346824-26-000079 2026-03-23T16:27:17-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-124231 2026-03-25T16:39:38-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/s-8/0001193125-26-134733 2026-03-31T17:38:20-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-168569 2026-04-22T08:16:40-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/def-14a/0001193125-26-197607 2026-04-30T16:46:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0001104659-26-054220 2026-05-01T16:58:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-204125 2026-05-04T16:36:50-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001193125-26-218195 2026-05-12T07:38:45-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0001193125-26-225169 2026-05-15T06:33:24-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0001727492-26-000011 2026-05-15T11:18:36-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001193125-26-226560 2026-05-15T16:01:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-275976 2026-06-18T16:36:35-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-25-009986 2026-06-26T06:05:42-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001193125-25-211554 2026-06-26T06:05:43-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/upload/0000000000-26-000022 2026-06-26T06:05:43-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001193125-26-002599 2026-06-26T06:05:44-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/corresp/0001193125-25-220723 2026-06-26T06:05:44-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-285722 2026-06-26T17:21:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-296936 2026-07-07T08:17:54-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001193125-26-336783 2026-08-06T07:59:05-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13da/0001346824-26-000220 2026-08-10T16:29:01-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13g/0000919574-26-004984 2026-08-12T12:10:09-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001172661-26-003437 2026-08-14T06:13:03-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0000919574-26-005263 2026-08-14T11:04:53-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001213900-26-090054 2026-08-14T16:14:57-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001831942-26-000035 2026-08-14T16:14:58-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001727492-26-000022 2026-08-14T16:53:32-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/schedule-13ga/0001193125-26-352646 2026-08-14T17:21:40-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/424b3/0001193125-26-361180 2026-08-21T16:32:04-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/4/0001193125-26-395552 2026-09-18T16:18:24-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/8-k/0001193125-26-419769 2026-10-13T08:37:34-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/25-nse/0001354457-26-001016 2026-10-22T16:24:13-04:00 0.4 https://ir.sabbiotherapeutics.com/sec-filings/sec-filing/10-q/0001193125-26-448600 2026-11-05T07:39:12-05:00 0.4 https://ir.sabbiotherapeutics.com/board-member/bill-polvino 2026-10-27T13:54:02-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/david-link 2026-10-27T15:18:44-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/samuel-reich 2026-10-27T15:19:42-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/eddie-sullivan-phd 2026-11-03T17:42:42-05:00 0.5 https://ir.sabbiotherapeutics.com/analyst/keay-nakae 2022-03-02T10:49:58-05:00 0.5 https://ir.sabbiotherapeutics.com/board-member/scott-giberson-rph-mph-dsc 2026-11-03T17:48:10-05:00 0.5 https://ir.sabbiotherapeutics.com/management/christoph-bausch-phd-mba 2026-11-03T17:49:38-05:00 0.5 https://ir.sabbiotherapeutics.com/management/alexandra-kropotova-md-mba 2026-11-03T17:46:42-05:00 0.5 https://ir.sabbiotherapeutics.com/analyst/emily-bodnar 2025-04-28T11:54:38-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/erick-lucera-cfa 2026-10-27T15:30:39-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/andrew-moin 2026-10-27T15:38:24-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/katie-ellias 2026-10-27T15:39:16-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/jay-skyler 2026-10-27T15:42:43-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/kumar-raja-phd 2024-06-10T11:21:54-04:00 0.5 https://ir.sabbiotherapeutics.com/management/lucy-to 2026-10-27T15:44:16-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/leland-gershell-md-phd 2024-09-06T10:53:46-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/albert-lowe-phd 2024-10-09T10:45:02-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/carlos-carrillo-phd-msc 2026-10-27T15:45:49-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/mark-conley-mba 2026-10-27T15:48:30-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/catherine-derose 2026-10-27T15:53:43-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/angie-parizek 2026-10-27T15:58:34-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/stan-stoyanov-md-mba 2026-10-27T16:53:41-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/hua-wu-phd 2026-10-27T17:03:41-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/todd-stahl 2026-10-27T17:05:07-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/thomas-smith 2025-10-28T09:47:20-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/yatin-suneja 2025-12-23T12:33:04-05:00 0.5 https://ir.sabbiotherapeutics.com/board-member/david-zaccardelli-pharmd 2026-10-27T17:06:19-04:00 0.5 https://ir.sabbiotherapeutics.com/board-member/rita-jain-md 2026-10-27T16:40:40-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/michael-yee 2026-01-12T08:43:51-05:00 0.5 https://ir.sabbiotherapeutics.com/analyst/seema-sheoran-phd 2026-04-13T11:01:42-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/eliana-merle-cfa 2026-06-26T14:30:49-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/roger-song-md-cfa 2026-06-26T14:35:00-04:00 0.5 https://ir.sabbiotherapeutics.com/analyst/geoff-meacham-phd 2026-07-29T13:06:09-04:00 0.5 https://ir.sabbiotherapeutics.com/clinical-advisory-board/colin-mark-dayan-ma-mbbs-frcp-phd 2026-10-28T19:33:29-04:00 0.5 https://ir.sabbiotherapeutics.com/clinical-advisory-board/michael-haller-md 2026-10-29T12:36:31-04:00 0.5 https://ir.sabbiotherapeutics.com/clinical-advisory-board/thomas-kay-mbbs 2026-10-29T12:51:39-04:00 0.5 https://ir.sabbiotherapeutics.com/clinical-advisory-board/chantal-mathieu-md-phd 2026-10-29T12:58:33-04:00 0.5 https://ir.sabbiotherapeutics.com/clinical-advisory-board/jay-s-skyler-md-macp-frcp 2026-10-29T13:00:02-04:00 0.5 https://ir.sabbiotherapeutics.com/clinical-advisory-board/john-wentworth-mbbs-fracp 2026-10-29T13:02:18-04:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/amisha-nair-phd 2026-11-05T13:43:14-05:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/andrea-bell-dhsc-msc-mba 2026-11-02T21:17:20-05:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/melanie-hansen 2026-11-02T21:21:10-05:00 0.5 https://ir.sabbiotherapeutics.com/senior-leadership/christine-ryan 2026-11-02T21:22:33-05:00 0.5